Back
Revance Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Sell
21
RVNC
Revance Therapeutics
Last Price:
5.86
Seasonality Move:
-5.59%
Sell
47
LLY
Eli Lilly and
Last Price:
915.51
Seasonality Move:
4.48%
Sell
21
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $5.99. The Score for RVNC is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $904.97. The Score for LLY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $5.99
The current trend is moderately bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $904.97
The current trend is relatively stagnant and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 48.82 | Sell |
Chaikin Money Flow: | -2917555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.31 - 6.71) | Sell |
Bollinger Bands (100): | (2.57 - 5.65) | Buy |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.67 | Buy |
Relative Strength Index (14 RSI): | 46.74 | Sell |
Chaikin Money Flow: | -1325849 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (913.47 - 951.51) | Sell |
Bollinger Bands (100): | (797.71 - 929.13) | Buy |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.35 | Sell |
20-day SMA: | 6.49 | Sell |
50-day SMA: | 5.16 | Buy |
200-day SMA: | 5.05 | Buy |
8-day EMA: | 6.25 | Sell |
20-day EMA: | 6.21 | Sell |
50-day EMA: | 5.42 | Buy |
200-day EMA: | 6.59 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 915.48 | Sell |
20-day SMA: | 932.76 | Sell |
50-day SMA: | 895.56 | Buy |
200-day SMA: | 778.51 | Buy |
8-day EMA: | 916.63 | Sell |
20-day EMA: | 918.54 | Sell |
50-day EMA: | 899.91 | Buy |
200-day EMA: | 786.32 | Buy |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $4.62 per share, an increase next quarter of $1.15 per share, an increase this year of $10.06 per share, and an increase next year of $6.23 per share.
Revance Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |